Molecular Templates to Present at the 29th Annual Piper Jaffray Healthcare Conference
AUSTIN, Texas, Nov. 21, 2017 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that Eric E. Poma, Ph.D., Chief Executive and Chief Scientific Officer, will provide a corporate overview at the 29th Annual Piper Jaffray Healthcare Conference, taking place November 28-29 at the Lotte New York Palace Hotel in New York City.
|
Molecular Templates Presentation Details | ||||
| Date: | Tuesday, November 28 | |||
| Time: | 9:30am Eastern Time | |||
| Location: | Lotte New York Palace Hotel, Track 6, Kennedy 1 Room | |||
| Webcast: | https://event.webcasts.com/starthere.jsp?ei=1171215&tp_key=3ce376224c | |||
About Molecular Templates
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases. For additional information, please visit Molecular Templates’ website at www.mtem.com.
Investor Contact:
Andrew McDonald, Ph.D.
andrew@lifesciadvisors.com
646-597-6987
